16-1184871-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_021098.3(CACNA1H):c.300-10101A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0826 in 151,552 control chromosomes in the GnomAD database, including 1,358 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.083 ( 1358 hom., cov: 34)
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.204
Publications
3 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.300-10101A>G | intron_variant | Intron 2 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | c.300-10101A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000454990.2 | ||||
| CACNA1H | ENST00000711493.1 | c.300-10101A>G | intron_variant | Intron 2 of 33 | ENSP00000518778.1 | |||||
| CACNA1H | ENST00000565831.7 | c.300-10101A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000455840.1 | ||||
| CACNA1H | ENST00000711450.1 | c.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000564231.6 | c.300-10101A>G | intron_variant | Intron 2 of 34 | 1 | ENSP00000457555.2 | ||||
| CACNA1H | ENST00000638323.1 | c.300-10101A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000492267.1 | ||||
| CACNA1H | ENST00000562079.6 | c.300-10101A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000454581.2 | ||||
| CACNA1H | ENST00000711438.1 | c.300-10101A>G | intron_variant | Intron 2 of 33 | ENSP00000518754.1 | |||||
| CACNA1H | ENST00000711482.1 | c.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.300-10101A>G | intron_variant | Intron 2 of 33 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000621827.2 | n.300-10101A>G | intron_variant | Intron 2 of 36 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.300-10101A>G | intron_variant | Intron 2 of 33 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.300-10101A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.300-10101A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.300-10101A>G | intron_variant | Intron 2 of 33 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.300-10101A>G | intron_variant | Intron 2 of 36 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.300-10101A>G | intron_variant | Intron 2 of 35 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.300-10101A>G | intron_variant | Intron 2 of 34 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0824 AC: 12478AN: 151434Hom.: 1348 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
12478
AN:
151434
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0826 AC: 12521AN: 151552Hom.: 1358 Cov.: 34 AF XY: 0.0811 AC XY: 6012AN XY: 74094 show subpopulations
GnomAD4 genome
AF:
AC:
12521
AN:
151552
Hom.:
Cov.:
34
AF XY:
AC XY:
6012
AN XY:
74094
show subpopulations
African (AFR)
AF:
AC:
10331
AN:
41150
American (AMR)
AF:
AC:
781
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
72
AN:
3468
East Asian (EAS)
AF:
AC:
188
AN:
5092
South Asian (SAS)
AF:
AC:
162
AN:
4810
European-Finnish (FIN)
AF:
AC:
220
AN:
10544
Middle Eastern (MID)
AF:
AC:
11
AN:
292
European-Non Finnish (NFE)
AF:
AC:
575
AN:
67926
Other (OTH)
AF:
AC:
147
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
531
1062
1592
2123
2654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
173
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.